Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea (Q34662897)

3 August 2017

title

Genetic polymorphisms in the 5-hydroxytryptamine type 3B receptor gene and paroxetine-induced nausea (English)

1 reference

3 August 2017

Masako Hosoi

10

0 references

Hisakazu Ohtani

object named as

Hisakazu Ohtani

11

0 references

Norio Ozaki

object named as

Norio Ozaki

4

0 references

Nakao Iwata

6

object named as

Nakao Iwata

1 reference

3 August 2017

5

Tatsuyo Suzuki

1 reference

3 August 2017

Misuzu Tanaka

1

1 reference

3 August 2017

Daisuke Kobayashi

2

1 reference

3 August 2017

Yuko Murakami

3

1 reference

3 August 2017

Koichi Haraguchi

7

1 reference

3 August 2017

Ichiro Ieiri

8

1 reference

3 August 2017

Naoko Kinukawa

9

1 reference

3 August 2017

Yasufumi Sawada

12

1 reference

3 August 2017

Kazunori Mine

13

1 reference

3 August 2017

publication date

13 August 2007

1 reference

The International Journal of Neuropsychopharmacology

3 August 2017

published in

1 reference

3 August 2017

volume

11

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

261-267

1 reference

Atomic force microscopy reveals the stoichiometry and subunit arrangement of 5-HT3 receptors

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Cisapride for the treatment of nausea produced by selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Mechanism of block by fluoxetine of 5-hydroxytryptamine3 (5-HT3)-mediated currents in NCB-20 neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

The 5-HT3B subunit is a major determinant of serotonin-receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

The pharmacological and functional characteristics of the serotonin 5-HT(3A) receptor are specifically modified by a 5-HT(3B) receptor subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Investigation of the human serotonin receptor gene HTR3B in bipolar affective and schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

The area postrema and vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Two naturally occurring amino acid substitutions of the 5-HT2A receptor: similar prevalence in patients with seasonal affective disorder and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Mechanism of the anti-emetic activity of 5-HT3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Paroxetine: an update of its use in psychiatric disorders in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Review of fluvoxamine safety database

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

The 5-HT3 antagonist ondansetron reduces gastrointestinal side effects induced by a specific serotonin re-uptake inhibitor in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

7 January 2021

Inhibition of a 5-HT3 receptor-mediated current by the selective serotonin uptake inhibitor, fluoxetine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

7 January 2021

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

7 January 2021

Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: Nonlinearity and relation to the sparteine oxidation polymorphism

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

7 January 2021

The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145707007985

7 January 2021

10.1017/S1461145707007985

Identifiers

DOI

0 references

1 reference